Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI
Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29, 2024 /PRNewswire/ — Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights,…